In a recent study, the evidence about angiogenesis became more clarified as OKN-007 combined with TMZ, resulted in a significant decrease in tumor progression by targeting the tumorigenic TGF-β1 pathway, which promotes angiogenesis among others [111]. The gene discussed is TGFB1; the disease is neoplasm.